¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immune adherence reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • consensual pupillary reaction
    °ø°¨µ¿°ø¹ÝÀÀ
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • counter reaction
    ¿ª¹ÝÀÀ
  • coupled reaction
    °ø¿ª¹ÝÀÀ, ¦Áø¹ÝÀÀ, ¿¬°á¹ÝÀÀ
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cutaneous drug reaction
    ÇǺξ๰¹ÝÀÀ
  • cutaneous reaction
    ÇǺιÝÀÀ
  • cytotoxic reaction
    ¼¼Æ÷µ¶¼º¹ÝÀÀ
  • cascade reaction
    ¿¬¼Ó´Ü°è¹ÝÀÀ
  • catalytic reaction
    Ã˸ŹÝÀÀ
  • catastrophic reaction
    ÆÄ±¹¹ÝÀÀ
  • cell-mediated reaction
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • cessation reaction
    Á¤Áö¹ÝÀÀ
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • blood transfusion reaction
    ¼öÇ÷¹ÝÀÀ
  • body righting reaction
    ¸öÅë¹Ù·ÎÀâ±â¹ÝÀÀ
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cadaveric reaction
    ½Ãü¹ÝÀÀ
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • Cannizzaro¡¯s reaction
    Ä«´ÏÂ¥·Î¹ÝÀÀ
  • capsular precipitation reaction
    Çù¸·Ä§°­¹ÝÀÀ
  • capsular swelling reaction
    (¢¡quellung reaction) ÆØÃ¢¹ÝÀÀ
  • carbamino reaction
    Ä«¸£¹Ù¹Ì³ë¹ÝÀÀ
  • cascade reaction
    ¿¬¼âÁõÆø¹ÝÀÀ
  • catalytic reaction
    Ã˸ŹÝÀÀ
  • cell-mediated reaction
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • cessation reaction
    Á¤Áö¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • immune-mediated urticaria
    ¸é¿ª ¸Å°³ µÎµå·¯±â
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡­Øóæ¹Úãëë).
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡­Øóæ¹Úãëë).
  • ADR : adverse drug reaction
    ¾à¹°À¯ÇØÀÛ¿ë(å·ÚªêóúªíÂéÄ).
  • Arthuss reaction
    ¾Æ¸£Åõ½º¹ÝÀÀ
  • Cannizzaros reaction
    Ä«´ÏÂ¥·Î¹ÝÀÀ.
  • Chediaks reaction
    ¼¼µð¾ÆÅ© ¹ÝÀÀ.
  • Dische reaction
    µð½¬¹ÝÀÀ.
  • Ehrlich reaction
    ¿¡¸£¸®È÷ ¹ÝÀÀ
  • Fernandez reaction
    Æä¸£³­µ¥½º ¹ÝÀÀ
  • Fernandezs reaction
    Æä¸£³­µ¥½º¹ÝÀÀ
  • Feulgens reaction
    Æ÷ÀϰչÝÀÀ
  • Fight or flight reaction
    µµÇǹÝÀÀ(Ô±ù­Úãëë)
  • Herxheimer s reaction
    Çì·Ï½ºÇÏÀ̸ӹÝÀÀ.
  • Herxheimer s reaction
    Ç츤½ºÇÏÀ̸ӹÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • immune ring
    ¸é¿ª°í¸®, ¸é¿ª·û
  • immune selection
    ¸é¿ª¼±ÅÃ
  • immune serum
    ¸é¿ªÇ÷û.
  • immune serum globulin
    ¸é¿ª Ç÷û ±Û·ÎºÒ¸°
  • immune serum globulin
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°.
  • immune serum globulin transfusion
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°¼öÇ÷
  • immune state
    ¸é¿ª»óÅÂ
  • immune surveillance
    ¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immune system
    ¸é¿ª°è(Øóæ¹Í§)
  • immune system
    ¸é¿ª°è.
  • immune thrombocytopenia
    ¸é¿ªÇ÷¼ÒÆÇ°áÇÌÁõ
  • immune tolerance
    ¸é¿ª°ü¿ë
  • immune-electron microscopy
    ¸é¿ªÀüÀÚÇö¹Ì°æ¹ý
  • immune-mediated hemolysis
    ¸é¿ª¸Å°³¼º ¿ëÇ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • Mehler reaction
    ¸á·¯ ¹ÝÀÀ(Úãëë)
  • Millon reaction
    ¹Ì¿ë ¹ÝÀÀ(Úãëë)
  • mixed-order reaction
    È¥ÇÕ¼øÂ÷ ¹ÝÀÀ(ûèùêâ÷ó­Úãëë)
  • monomolecular reaction
    ´ÜºÐÀÚ¹ÝÀÀ(Ó¤ÝÂí­Úãëë)
  • ninhydrin reaction
    ´ÑÈ÷µå¸°¹ÝÀÀ(Úãëë)
  • nitroprusside reaction
    ³ªÀÌÆ®·ÎǪ·ç½Ãµå ¹ÝÀÀ(Úãëë)
  • nucleotide exchange reaction
    ´©Å¬¸®¿ÀŸÀÌµå ±³È¯¹ÝÀÀ(ÎßüµÚãëë)
  • opposing unidirectional reaction
    ¿ª ÀϹæÇâ¹ÝÀÀ(æ½ìéÛ°ú¾Úãëë)
  • orcinol reaction
    ¿À¸£½Ã³î ¹ÝÀÀ(Úãëë)
  • oscillating reaction
    Áøµ¿¹ÝÀÀ(òÉÔÑÚãëë)
  • oxidation-reduction reaction
    »êȭȯ¿ø ¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • oxidoreduction reaction
    »êȭȯ¿ø¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • partial reaction
    ºÎºÐ ¹ÝÀÀ(Ý»ÝÂÚãëë)
  • Pauly reaction
    ÆÄ¿ï¸® ¹ÝÀÀ(Úãëë)
  • pericyclic reaction
    °í¸®Çü Çùµ¿¹ÝÀÀ(úðÔÒÚãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
ISG Immune Serum Globulin
ITP Idiopathic(Immune) Thrombocytopenic Purpura
RIG Rabies Immune Globulin
RIPA Radio-Immuno(= Immune)-Precipitation(Precipitin) Assay
TIG: (human) Tetanus Immune(Immuno-) Globulin ÆÄ»ódz Àΰ£ ¸é¿ª ±Û·ÎºÒ¸°
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
ISG Immune serum globulin
ISC Immune spleen cells
IS Immune suppression
ITP Immune thrombocytopenia
ITI Immune tolerance induction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • leukematoid reaction
    ¹éÇ÷¼º ¹ÝÀÀ
  • leukoerythroblastic reaction
    ¹éÀû¾Æ±¸¼º ¹ÝÀÀ
  • lichenoid drug reaction
    ż±¾ç ¾à¹° ¹ÝÀÀ
  • magnet reaction
    ÀÚ¼® ¹ÝÀÀ
  • monomolecular reaction
    ´Ü ºÐÀÚ ¹ÝÀÀ
  • Nadi reaction
    ³ªµð ¹ÝÀÀ
    ³ªµð ½Ã¾àÀ» µ¿¹°¿¡ ÁÖ»çÇϸé, Ä¡ÅäÅ©·Ò »êÈ­ È¿¼ÒÀÇ ÀÛ¿ë¿¡ ÀÇÇØ Ä¡ÅäÅ©·ÒÀ¸·ÎºÎÅÍ Àεµ Æä³î ûÀÌ Çü¼ºµÇ´Â ¹ÝÀÀÀÌ´Ù.
  • Napier's reaction
    ³ªÇÇ¾î ¹ÝÀÀ
    Ä®¶ó¾ÆÀÚ¸£¸¦ Áø´ÜÇÏ´Â µ¥ »ç¿ëµÇ´Â ¹ÝÀÀÀ¸·Î, Ç÷û 1 cc¿¡ Æ÷¸£¸»¸° ÇÑ ¹æ¿ïÀ» °¡ÇѸé, ±Û·ÎºÒ¸°ÀÇ Áõ°¡·Î ÀÎÇØ ¹éŹÀÌ ¹ß»ýÇÏ´Â Çö»óÀÌ´Ù.
  • Neill-Mooser reaction
    ´Ò-¹«Àú ¹ßÁø¿­ °Ë»ç
  • ninhydrin reaction
    ´ÑÈ÷µå¸° ¹ÝÀÀ
    µ¿ÀǾî=Abderhalden's reaction. ¸ðµç ´Ü¹éÁú ¹× ¾Æ¹Ì³ë»ê¿¡ ƯÀÌÇÑ ¹ÝÀÀÀ¸·Î, ²úÀ̸é û»öÀÌ µÇ°í, ÇǸ®µò¿¡ ÀÇÇØ ´õ¿í ÁøÇØÁö´Â ÀӽйÝÀÀ.
  • nitroso- ´ÏÆ®·Î¼Ò ¶Ç´Â ´ÏÆ®·Î½ÇÀ» ÇÔÀ¯Çϰí ÀÖÀ½À» ³ªÅ¸³»´Â Á¢µÎ¾î.

    nitrosoindol reaction

    ´ÏÆ®·Î Àε¹ ¹ÝÀÀ
  • nociceptive reaction
    Ä§ÇØ ¹ÝÀÀ
  • nonspecific reaction
    ºñƯÀÌ ¹ÝÀÀ
  • order of reaction
    ¹ÝÀÀ Â÷¼ö
  • overanxious reaction
    °úºÒ¾È ¹ÝÀÀ
  • oxidase reaction
    »êÈ­ È¿¼Ò ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
beam-plasma reaction <radiobiology> Fusion reaction which occurs from the collision of a fast beam ion with a thermal plasma ion.
(09 Oct 1997)
beam-wall reaction <radiobiology> Fusion reaction which occurs from the collision of a fast beam ion with an ion embedded in or adsorbed onto the reactor wall.
(09 Oct 1997)
Bence Jones reaction <investigation> The classic method of identifying Bence Jones protein. This protein precipitates from urine in the range of 45 to 70 degrees Centigrade. It goes into solution at temperatures above or below this range. Used in the diagnosis of multiple myeloma. Less commonly, this test is positive in Waldenstrom's macroglobulinaemia, chronic lymphocytic leukaemia and amyloidosis.
(27 Sep 1997)
Berthelot reaction The reaction of ammonia with phenol-hypochlorite to give indophenol; the principle is used to analyze ammonia concentration in body fluids.
(05 Mar 2000)
bi-bi reaction A reaction catalyzed by a single enzyme in which two substrates and two products are involved; the ping-pong mechanism may be involved in such a reaction.
Compare: mechanism.
(05 Mar 2000)
Bittorf's reaction In cases of renal colic, pain radiating to the kidney upon squeezing the testicle or pressing the ovary.
(05 Mar 2000)
biuret reaction A reaction characterised by a violet colour upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids.
(12 Dec 1998)
Bloch's reaction A dark staining observed in fresh tissue sections to which a solution of dopa has been applied, presumably due to the presence of dopa oxidase in the protoplasm of certain cells.
Synonym: Bloch's reaction.
(05 Mar 2000)
blood transfusion reaction This refers to an immune response against transfused blood cells. Antigens, on the surface of red blood cells, are recognised as foreign proteins and can stimulate sensitised lymphocytes to produce antibodies to the red blood cell antigens. This triggers a complex immunological reaction that results in the destruction of the transfused red blood cell. The blood groups (A, B, AB, O) are classified on the basis of the presence of surface antigens on the red blood cell. Type A blood has A antigens. The plasma component of the blood contains the antibodies against all other blood group antigens other that its own. Another type of surface antigen is known as Rh factor. Rh factor is either present (Rh positive) or absent (Rh negative). Rh compatibility is another requirement for blood transfusion.
Symptoms and findings of a transfusion reaction include flank pain, fever, chills, bloody urine, rash, low blood pressure, dizziness and fainting.
(27 Sep 1997)
Bordet and Gengou reaction <immunology> Binding of complement as a result of its interaction with immune complexes (the classical pathway) or particular surfaces (alternative pathway).
(18 Nov 1997)
Brunn reaction The increased absorption of water through the skin of the frog when the animal is injected with pituitrin and immersed in water; one of the physiological reactions used to study and classify posterior pituitary polypeptides and their analogues.
(05 Mar 2000)
Burchard-Liebermann reaction A blue-green colour produced by acetic anhydride with cholesterol (and other sterols) dissolved in chloroform, when a few drops of concentrated sulfuric acid are added.
See: Liebermann-Burchard test.
(05 Mar 2000)
Cannizzaro's reaction Formation of an acid and an alcohol by the simultaneous oxidation of one aldehyde molecule and reduction of another; a dismutation: 2RCHO &rarr; RCOOH + RCH2OH; when the aldehydes are not identical, this is referred to as a crossed Cannizzaro reaction.
(05 Mar 2000)
capsular precipitation reaction Swelling of the capsule surrounding a bacterium as a result of interaction with anticapsular antibody, consequently the capsule becomes more refractile and conspicuous.
(18 Nov 1997)
vaccinoid reaction A response occurring in a shorter time than expected; the cutaneous manifestations occurring during the period between the second and tenth day following smallpox vaccination; because it is intermediate between a primary reaction and an immediate reaction, it is regarded as evidence of some degree of resistance.
Synonym: vaccinoid reaction.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á